
### [NCIT:C7372](http://purl.obolibrary.org/obo/NCIT_C7372)
**Label:** Cerebellar Neuronal and Mixed Neuronal-Glial Tumor

**Subclasses:** [NCIT:C8419](http://purl.obolibrary.org/obo/NCIT_C8419) (Dysplastic Cerebellar Gangliocytoma), [NCIT:C6905](http://purl.obolibrary.org/obo/NCIT_C6905) (Cerebellar Liponeurocytoma), 

**Class expressions from DL-Learner:**

- [NCIT:C42092](http://purl.obolibrary.org/obo/NCIT_C42092) (Neoplastic Round Neuroepithelial Cell) 53.33%
- [NCIT:C42085](http://purl.obolibrary.org/obo/NCIT_C42085) (Dysplastic Ganglion Cell) 53.33%
- Thing 53.15%
- [NCIT:C37146](http://purl.obolibrary.org/obo/NCIT_C37146) (Neoplastic Ganglion Cell) 47.49%
- [NCIT:C37146](http://purl.obolibrary.org/obo/NCIT_C37146) (Neoplastic Ganglion Cell) and (not ([NCIT:C39914](http://purl.obolibrary.org/obo/NCIT_C39914) (Gain of Chromosome 12p))) 47.49%
- [NCIT:C37146](http://purl.obolibrary.org/obo/NCIT_C37146) (Neoplastic Ganglion Cell) and (not ([NCIT:C3991](http://purl.obolibrary.org/obo/NCIT_C3991) (Thrombocytopenia Due to Immune Destruction))) 47.49%
- [NCIT:C37146](http://purl.obolibrary.org/obo/NCIT_C37146) (Neoplastic Ganglion Cell) and (not ([NCIT:C39909](http://purl.obolibrary.org/obo/NCIT_C39909) (Gain of Chromosome 18q))) 47.49%
- [NCIT:C37146](http://purl.obolibrary.org/obo/NCIT_C37146) (Neoplastic Ganglion Cell) and (not ([NCIT:C39907](http://purl.obolibrary.org/obo/NCIT_C39907) (Seminal Vesicle Cystadenoma))) 47.49%
- [NCIT:C37146](http://purl.obolibrary.org/obo/NCIT_C37146) (Neoplastic Ganglion Cell) and (not ([NCIT:C39906](http://purl.obolibrary.org/obo/NCIT_C39906) (Seminal Vesicle Adenocarcinoma))) 47.49%
- [NCIT:C37146](http://purl.obolibrary.org/obo/NCIT_C37146) (Neoplastic Ganglion Cell) and (not ([NCIT:C39905](http://purl.obolibrary.org/obo/NCIT_C39905) (Prostate Stromal Proliferation of Uncertain Malignant Potential))) 47.49%
- [NCIT:C37146](http://purl.obolibrary.org/obo/NCIT_C37146) (Neoplastic Ganglion Cell) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 47.49%
- [NCIT:C37146](http://purl.obolibrary.org/obo/NCIT_C37146) (Neoplastic Ganglion Cell) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 47.49%
- [NCIT:C37146](http://purl.obolibrary.org/obo/NCIT_C37146) (Neoplastic Ganglion Cell) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 47.49%
- [NCIT:C37146](http://purl.obolibrary.org/obo/NCIT_C37146) (Neoplastic Ganglion Cell) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 47.49%
- [NCIT:C37146](http://purl.obolibrary.org/obo/NCIT_C37146) (Neoplastic Ganglion Cell) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 47.49%


